URALCHEM reports the results of the Annual General Meeting of Shareholders
URALCHEM reports the results of the Annual General Meeting of
Shareholders
United Chemical Company URALCHEM, OJSC reports on the decisions taken by the shareholders at the
Annual General Meeting held on 30th June, 2014.
Moscow, Russia (July 2, 2014) -- United Chemical Company URALCHEM, OJSC reports on the decisions taken by the shareholders at the Annual General Meeting held on 30th June, 2014.
The company's shareholders approved URALCHEM's annual report and annual financial statements for fiscal year
2013. The shareholders decided not to announce and pay dividends for 2013, beyond the 3.475 billion roubles previously announced for the nine months of 2013.
The meeting also re-elected the current Board of Directors of URLACHEM OJSC. The board includes Dmitry Mazepin,
Dmitry Tatianin, Dmitry Konyaev, Julia Orlovskaya, Andrey Pakhomenkov, Mikhail Genkin and independent director
Petr Krupnov.
The shareholders' approved the new edition of the articles of association of the company, which brings it into line with changes in legislation and specifies the responsibilities of the CEO and the Board of Directors. The meeting approved a major deal: namely, the signing of an additional agreement to the VTB loan to purchase shares in OJSC Uralkali, which increased the period of availability of undrawn funds to the end of 2014.
Dmitry Konyaev, CEO of URALCHEM, OJSC said that in 2013 the company demonstrated the stability of the business in difficult market conditions. Among the main results of the year were the completion of its own port terminal in Riga and the purchase of 19.99% of shares in OJSC Uralkali. In 2014, the company will focus on improving business efficiency by continuing to invest in the renovation and modernization of its existing facilities.
Public Relations Department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89 pr@uralchem.com http://www.uralchem.com
URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilizers in
Shareholders
United Chemical Company URALCHEM, OJSC reports on the decisions taken by the shareholders at the
Annual General Meeting held on 30th June, 2014.
Moscow, Russia (July 2, 2014) -- United Chemical Company URALCHEM, OJSC reports on the decisions taken by the shareholders at the Annual General Meeting held on 30th June, 2014.
The company's shareholders approved URALCHEM's annual report and annual financial statements for fiscal year
2013. The shareholders decided not to announce and pay dividends for 2013, beyond the 3.475 billion roubles previously announced for the nine months of 2013.
The meeting also re-elected the current Board of Directors of URLACHEM OJSC. The board includes Dmitry Mazepin,
Dmitry Tatianin, Dmitry Konyaev, Julia Orlovskaya, Andrey Pakhomenkov, Mikhail Genkin and independent director
Petr Krupnov.
The shareholders' approved the new edition of the articles of association of the company, which brings it into line with changes in legislation and specifies the responsibilities of the CEO and the Board of Directors. The meeting approved a major deal: namely, the signing of an additional agreement to the VTB loan to purchase shares in OJSC Uralkali, which increased the period of availability of undrawn funds to the end of 2014.
Dmitry Konyaev, CEO of URALCHEM, OJSC said that in 2013 the company demonstrated the stability of the business in difficult market conditions. Among the main results of the year were the completion of its own port terminal in Riga and the purchase of 19.99% of shares in OJSC Uralkali. In 2014, the company will focus on improving business efficiency by continuing to invest in the renovation and modernization of its existing facilities.
Public Relations Department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89 pr@uralchem.com http://www.uralchem.com
URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilizers in